Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGC NASDAQ:CRON OTCMKTS:STDAF NASDAQ:TLRY NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.12+0.9%$1.07$0.84▼$2.38$448.58M0.7814.70 million shs6.39 million shsCRONCronos Group$2.75+8.3%$2.59$1.84▼$3.43$955.73M0.872.06 million shs4.65 million shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$5.51-0.9%$6.70$3.51▼$23.20$648.01M1.947.90 million shs3.60 million shsUSNAUSANA Health Sciences$17.45-8.0%$18.33$16.60▼$38.32$349.94M0.7795,710 shs132,040 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth0.00%-1.77%+5.71%+1.83%-15.91%CRONCronos Group0.00%-3.79%-1.55%-3.05%+28.28%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands0.00%-9.74%-15.37%-27.79%+30.21%USNAUSANA Health Sciences0.00%-1.55%+4.45%-10.02%-35.64%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.12+0.9%$1.07$0.84▼$2.38$448.58M0.7814.70 million shs6.39 million shsCRONCronos Group$2.75+8.3%$2.59$1.84▼$3.43$955.73M0.872.06 million shs4.65 million shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$5.51-0.9%$6.70$3.51▼$23.20$648.01M1.947.90 million shs3.60 million shsUSNAUSANA Health Sciences$17.45-8.0%$18.33$16.60▼$38.32$349.94M0.7795,710 shs132,040 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth0.00%-1.77%+5.71%+1.83%-15.91%CRONCronos Group0.00%-3.79%-1.55%-3.05%+28.28%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands0.00%-9.74%-15.37%-27.79%+30.21%USNAUSANA Health Sciences0.00%-1.55%+4.45%-10.02%-35.64%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 2.00HoldN/AN/ACRONCronos Group 2.20Hold$2.30-16.36% DownsideSTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/ATLRYTilray Brands 2.25Hold$11.50108.71% UpsideUSNAUSANA Health Sciences 1.50ReduceN/AN/ACurrent Analyst Ratings BreakdownLatest CGC, TLRY, STDAF, CRON, and USNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/4/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/29/2026TLRYTilray Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/22/2026USNAUSANA Health Sciences Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/20/2026CGCCanopy Growth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/13/2026USNAUSANA Health Sciences Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/2/2026TLRYTilray Brands ATB Cormark Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$9.50 ➝ $9.004/2/2026TLRYTilray Brands Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$10.003/30/2026TLRYTilray Brands TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$10.00 ➝ $7.003/27/2026USNAUSANA Health Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)3/27/2026CGCCanopy Growth Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy3/17/2026CGCCanopy Growth ATB Cormark Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Moderate Buy(Data available from 5/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$225.65M2.01N/AN/A$1.90 per share0.59CRONCronos Group$146.59M7.06$0.01 per share202.60$3.00 per share0.92STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78TLRYTilray Brands$821.31M0.78$1.43 per share3.85$14.04 per share0.39USNAUSANA Health Sciences$925.26M0.35$3.80 per share4.59$29.16 per share0.60Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$429.86M-$1.30N/AN/AN/A-94.39%-46.85%-28.95%5/29/2026 (Estimated)CRONCronos Group-$9.45M-$0.01N/AN/AN/A-6.44%-1.12%-1.07%5/11/2026 (Estimated)STDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$13.65N/AN/AN/A-156.51%-3.31%-2.42%7/27/2026 (Estimated)USNAUSANA Health Sciences$10.76M$0.4737.136.300.750.96%6.21%4.50%7/28/2026 (Estimated)Latest CGC, TLRY, STDAF, CRON, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/29/2026Q4 2026CGCCanopy Growth-$0.06N/AN/AN/A$53.43 millionN/A5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 millionN/A5/5/2026Q1 2026USNAUSANA Health Sciences$0.44$0.61+$0.17$0.41$240.99 million$250.22 million4/1/2026Q3 2026TLRYTilray Brands-$0.14-$0.24-$0.10-$0.24$201.35 million$206.73 million2/26/2026Q4 2025CRONCronos Group$0.01$0.02+$0.01N/A$38.51 million$58.39 million2/17/2026Q4 2025USNAUSANA Health Sciences$0.41$0.60+$0.19-$0.10$225.96 million$226.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.305.344.26CRONCronos GroupN/A19.5918.62STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99TLRYTilray Brands0.192.791.66USNAUSANA Health SciencesN/A2.511.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth0.16%CRONCronos Group7.80%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands0.84%USNAUSANA Health Sciences0.82%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth3,150404.12 million403.48 millionOptionableCRONCronos Group450376.27 million346.92 millionOptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableTLRYTilray Brands2,842116.55 million115.57 millionOptionableUSNAUSANA Health Sciences1,57018.46 million18.31 millionOptionableCGC, TLRY, STDAF, CRON, and USNA HeadlinesRecent News About These CompaniesInsider Selling: USANA Health Sciences (NYSE:USNA) Insider Sells $75,137.62 in StockMay 11 at 4:35 AM | americanbankingnews.comInsider Selling: USANA Health Sciences (NYSE:USNA) Insider Sells 3,791 Shares of StockMay 9 at 6:59 AM | insidertrades.comUSANA Health Sciences (NYSE:USNA) Insider Sells $75,137.62 in StockMay 8 at 3:27 PM | marketbeat.comUSANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?May 8 at 1:01 PM | zacks.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?May 8 at 10:40 AM | zacks.comUSANA Health Sciences, Inc. Just Recorded A 78% EPS Beat: Here's What Analysts Are Forecasting NextMay 8 at 8:52 AM | finance.yahoo.comSidoti Equities Analysts Raise Earnings Estimates for USNAMay 8 at 8:01 AM | marketbeat.comUSANA Health: Q1 Earnings SnapshotMay 7, 2026 | chron.comUSANA's People-First Culture Earns Spot on USA TODAY Top Workplaces ListMay 7, 2026 | prnewswire.comUSANA (NYSE:USNA) Delivers Impressive Q1 CY2026May 7, 2026 | finance.yahoo.comUSANA (USNA) Q1 2026 Earnings Call TranscriptMay 7, 2026 | aol.comAUSANA Health Sciences Signals Confident 2026 Growth PathMay 6, 2026 | tipranks.comUSANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comUSANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass EstimatesMay 5, 2026 | zacks.comUSANA Health Sciences (NYSE:USNA) Posts Quarterly Earnings Results, Beats Estimates By $0.17 EPSMay 5, 2026 | marketbeat.comUSANA Health Q1 2026 Results Highlight Mixed PerformanceMay 5, 2026 | tipranks.comUSANA Health Sciences (NYSE:USNA) Releases FY 2026 Earnings GuidanceMay 5, 2026 | marketbeat.comUSANA (USNA) Q1 Earnings: What To ExpectMay 4, 2026 | finance.yahoo.comUSANA Health Sciences (USNA) Projected to Post Quarterly Earnings on TuesdayMay 3, 2026 | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Stock Rating Lowered by Wall Street ZenMay 2, 2026 | marketbeat.comDuring National Show Your Smile Month, Kevin Guest Urges Leaders to Lift Others DailyMay 1, 2026 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesASML Falls Post-Earnings, Chip-Making Expansion Anchors OutlookBy Leo Miller | April 16, 2026GPU Prices Are Surging—3 Ways to Play the AI Chip ShortageBy Thomas Hughes | April 14, 2026STMicronelectronics Sends Industrial Chips Into OverdriveBy Thomas Hughes | April 24, 2026The Cannabis Sector's Billion-Dollar Tax CutBy Jeffrey Neal Johnson | April 23, 2026This New ETF Aims to Capitalize on Surging AI Memory Chip DemandBy Jessica Mitacek | April 13, 2026CGC, TLRY, STDAF, CRON, and USNA Company DescriptionsCanopy Growth NASDAQ:CGC$1.12 +0.01 (+0.90%) Closing price 04:00 PM EasternExtended Trading$1.12 +0.00 (+0.45%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.75 +0.21 (+8.27%) Closing price 04:00 PM EasternExtended Trading$2.72 -0.03 (-1.13%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Tilray Brands NASDAQ:TLRY$5.51 -0.05 (-0.90%) Closing price 04:00 PM EasternExtended Trading$5.51 +0.00 (+0.07%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$17.45 -1.51 (-7.96%) Closing price 03:59 PM EasternExtended Trading$17.40 -0.05 (-0.26%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MercadoLibre Boldly Invests in Growth: Discount Deepens Manic Monday.com: The Rally Is Just the Beginning for this SaaS Leader 5 Stocks Positioned to Benefit From the AI Inference Boom Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand Now Tapestry Stock Drops After Strong Quarter and Raised Outlook MarketBeat Week in Review – 05/04 - 05/08 Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
